Merit Medical has revealed positive six-month data from a trial investigating its endoprosthesis in dialysis patients who ...

The trial compares Eli Lilly’s lutetium zadavotide guraxetan with Astellas’s Xtandi or Janssen’s Zytiga for mPRPC.

The comments on the new FDA draft guidance must be submitted by 16 November. Image credit: Tada Images / Shutterstock. The US Food and Drug Administration (FDA) has released a new draft guidance on ...

The US Food and Drug Administration (FDA) has lifted a clinical hold on Zentalis Pharmaceuticals’ azenosertib. Credit: PeopleImages.com – Yuri A via Shutterstock. The US Food and Drug Administration ...

The trial enrolled 1,324 patients with unresectable hepatocellular carcinoma. Credit: Jo Panuwat D / Shutterstock. UK-based pharmaceutical company AstraZeneca has reported positive results from the ...

The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.

As Ipsen pivots away from Cabometyx in mCRPC, US rights holder Exelixis will press ahead with a submission to the FDA.

Pfizer’s cancer cachexia candidate has provided patients with clinically meaningful weight gain in a Phase II trial, with the ...

The ongoing Phase I trial is evaluating the drug’s safety, tolerability, and efficacy in adult patients. Credit: New Africa/Shutterstock. Daiichi Sankyo has reported positive initial findings from the ...

Platinum-based therapies remain the mainstay treatment for patients with endometrial (EC) and ovarian cancers (OC). However, both cancers are frequently marked by recurrence and the eventual ...

Hepatocellular carcinoma is a type of adjuvant liver cancer. Credit: David A Litman via shutterstock.com. Advanced hepatocellular carcinoma (aHCC) has a dire prognostic outlook, with an 18.4% ...

At the European Society of Medical Oncology (ESMO) Congress 2024, updated efficacy and safety data from the randomised, controlled Phase III IMbrave050 clinical trial were presented on 13 September.